ASSET PURCHASE AGREEMENT BY AND BETWEEN BIOVAIL LABORATORIES INTERNATIONAL SRL, AS BUYER, AND CORTEX PHARMACEUTICALS, INC., AS SELLERAsset Purchase Agreement • May 17th, 2010 • Cortex Pharmaceuticals Inc/De/ • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”), dated as of March 25, 2010 (the “Effective Date”), is made by and between Cortex Pharmaceuticals, Inc., a Delaware corporation (“Seller”) and Biovail Laboratories International SRL, an international society with restricted liability organized under the laws of Barbados (“Buyer”). Buyer and Seller may be referred to herein each individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • May 17th, 2010 • Cortex Pharmaceuticals Inc/De/ • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) dated as of March 25, 2010, is made between CORTEX PHARMACEUTICALS, INC., a Delaware corporation (“Cortex”), and BIOVAIL LABORATORIES INTERNATIONAL SRL, an international society with restricted liability organized under the laws of Barbados (“BLS”).
